Smith Thomas B
CIK 0001748462
EVP and Chief Medical Officer
Filings
9
Latest Feb 12, 2026
Issuers covered
2
Showing
9 of 9
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | +1.2% | -1.3% | +10.9% | -5.9% |
| 90 days | 3 | 67% | +3.0% | +9.6% | +19.8% | -20.3% |
| 180 days | 3 | 33% | +0.0% | -2.9% | +21.0% | -17.9% |
| 365 days | 2 | 100% | +13.9% | +13.9% | +20.9% | +6.9% |
Issuers
Companies where Smith Thomas B has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| COLL | Collegium Pharmaceutical, Inc | 7 | Feb 12, 2026 |
| BDSI | Biodelivery Sciences International Inc | 2 | Mar 22, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|